PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 49 filers reported holding PEAR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,511 | -85.0% | 37,296 | -30.4% | 0.00% | – |
| Q4 2022 | $63,202 | +29.0% | 53,560 | +121.0% | 0.00% | – |
| Q3 2022 | $49,000 | +1533.3% | 24,234 | +991.1% | 0.00% | – |
| Q2 2022 | $3,000 | -89.7% | 2,221 | -60.6% | 0.00% | – |
| Q1 2022 | $29,000 | +93.3% | 5,641 | +132.9% | 0.00% | – |
| Q4 2021 | $15,000 | – | 2,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arboretum Ventures, LLC | 10,859,050 | $2,769,058 | 8.16% |
| Palantir Technologies Inc. | 700,000 | $178,500 | 1.14% |
| 5AM Venture Management, LLC | 16,744,113 | $4,269,749 | 1.09% |
| TB Alternative Assets Ltd. | 2,071,865 | $528,326 | 0.13% |
| EDBI Pte Ltd | 427,070 | $108,903 | 0.12% |
| Temasek Holdings (Private) Ltd | 26,803,573 | $6,834,911 | 0.04% |
| SoftBank Group | 12,100,078 | $3,085,520 | 0.04% |
| Sarissa Capital Management LP | 500,356 | $127,591 | 0.02% |
| Perceptive Advisors | 900,548 | $229,639 | 0.01% |
| Legal & General Group Plc | 7,198 | $1,836 | 0.00% |